相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, lymphocyte-monocyte ratio and platelets in prognosis of patients with prostate cancer
Joanna Huszno et al.
ONCOLOGY LETTERS (2022)
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
Matthew P. Deek et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Neutrophil Lymphocyte Ratio to Albumin Ratio and White Blood Cell to Hemoglobin Ratio as Prognostic Markers for Hepatocellular Carcinoma Patients Who Underwent Curative Hepatectomy
Xueqin Shen et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited
Matthew P. Deek et al.
EUROPEAN UROLOGY (2021)
Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies - Executive summary
Andrea Kokorovic et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2021)
Local Therapies in Oligometastatic and Oligoprogressive Prostate Cancer
Matthew P. Deek et al.
SEMINARS IN RADIATION ONCOLOGY (2021)
Exploring miRNA Signature and Other Potential Biomarkers for Oligometastatic Prostate Cancer Characterization: The Biological Challenge behind Clinical Practice. A Narrative Review
Giulia Corrao et al.
CANCERS (2021)
Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review
Kim Van der Eecken et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer
Matthew P. Deek et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
The Preoperative Prognostic Nutritional Index Predicts Short-Term and Long-Term Outcomes of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-Institution Dataset
Masahiro Sasahara et al.
DIGESTIVE SURGERY (2020)
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer The ORIOLE Phase 2 Randomized Clinical Trial
Ryan Phillips et al.
JAMA ONCOLOGY (2020)
Controlling Nutritional Status score: A new prognostic indicator for patients with oligometastatic prostate cancer
Wentao Zhang et al.
CURRENT PROBLEMS IN CANCER (2019)
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
David A. Palma et al.
LANCET (2019)
Radioablation plus /- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)
Giulia Marvaso et al.
BMC CANCER (2019)
Usefulness of the preoperative prognostic nutritional index score as a predictor of the outcomes of lung transplantation: A single-institution experience
Chi Young Kim et al.
CLINICAL NUTRITION (2019)
A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer
Pieter J. L. De Visschere et al.
EUROPEAN UROLOGY ONCOLOGY (2019)
The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score is a Novel Significant Prognostic Factor for Patients with Metastatic Prostate Cancer Undergoing Cytoreductive Radical Prostatectomy
Yadong Guo et al.
JOURNAL OF CANCER (2019)
Role of Neutrophil to Lymphocyte Ratio or Platelet to Lymphocyte Ratio in Prediction of Bone Metastasis of Prostate Cancer
Jing-Ya Zhang et al.
CLINICAL LABORATORY (2019)
Metabolic changes in patients with prostate cancer during androgen deprivation therapy
Koji Mitsuzuka et al.
INTERNATIONAL JOURNAL OF UROLOGY (2018)
Systemic immune-inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration-resistant prostate cancer patients
Liancheng Fan et al.
PROSTATE (2018)
Preoperative nutritional status assessment predicts postoperative outcomes in patients with surgically resected non-small cell lung cancer
Ricard Ramos et al.
EJSO (2018)
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
Piet Ost et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy
Ding Peng et al.
SCIENTIFIC REPORTS (2018)
Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy
Ding Peng et al.
BMC UROLOGY (2018)
PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact
Bernhard Grubmueller et al.
CLINICAL CANCER RESEARCH (2018)
Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration-resistant prostate cancer patients treated with abiraterone
Liancheng Fan et al.
PROSTATE (2017)
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Prostate Cancer A Systematic Review and Meta-analysis
Xiaotao Yin et al.
MEDICINE (2016)
Preoperative combined hemoglobin, albumin, lymphocyte and platelet levels predict survival in patients with locally advanced colorectal cancer
Huihong Jiang et al.
ONCOTARGET (2016)
Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients
Xiaobin Gu et al.
SCIENTIFIC REPORTS (2016)
Prostate cancer biomarkers: Are we hitting the mark?
Shannon McGrath et al.
PROSTATE INTERNATIONAL (2016)
Platelet-to-lymphocyte ratio predicts prostate cancer prognosis
Peter Sidaway
Nature Reviews Urology (2015)
Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study
Xiao-Long Chen et al.
ONCOTARGET (2015)
Baseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use
D. Lorente et al.
ANNALS OF ONCOLOGY (2015)
Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer
Xiaoan Liu et al.
CARCINOGENESIS (2015)
Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis
Cecilia Bosco et al.
PLOS ONE (2015)
CANCER Inflammation lights the way to metastasis
Seth B. Coffelt et al.
NATURE (2014)
Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy
Patrick Berkovic et al.
CLINICAL GENITOURINARY CANCER (2013)
Nutrition and Physical Activity Guidelines for Cancer Survivors
Cheryl L. Rock et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Natural immunity to cancer in humans
Gabriela Bindea et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma
FJ Fowler et al.
CANCER (2002)
Single-therapy androgen suppression in men with advanced prostate cancer: A systematic review and meta-analysis
J Seidenfeld et al.
ANNALS OF INTERNAL MEDICINE (2000)
分享论文
